Drug-induced autoimmune disease.
D000123:Acetyltransferases / Q000378:metabolism; D000974:Antibodies, Antinuclear; D000918:Antibody Specificity; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000201:enzymology / Q000276:immunology / Q000378:metabolism; D001665:Binding Sites; D004247:DNA / Q000378:metabolism; D000939:Epitopes; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects* / Q000378:metabolism; D005779:Immunodiffusion; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000201:enzymology / Q000276:immunology / Q000378:metabolism; D009690:Nucleic Acid Conformation; D009698:Nucleoproteins / Q000378:metabolism; D011342:Procainamide / Q000009:adverse effects* / Q000378:metabolism; D011485:Protein Binding
D000974:Antibodies, Antinuclear; D000939:Epitopes; D009698:Nucleoproteins; D006830:Hydralazine; D004247:DNA; D000123:Acetyltransferases; D011342:Procainamide